Transplantation material bovine pericardium: Biomechanical and immunogenic characteristics after decellularization vs. glutaraldehyde-fixing

Xenotransplantation

Volumn 19, Issue 5, 2012, Pages 286-297

  Hülsmann, Jörn ^a,b   Grün, Katja ^b   El Amouri, Sonya ^a   Barth, Mareike ^a,d   Hornung, Katrin ^b   Holzfuß, Carlheinz ^c   Lichtenberg, Artur ^a,b   Akhyari, Payam ^a,b  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY OF APPLIED SCIENCES JENA   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

alpha Gal; biomaterials; bovine pericardium; decellularization; elastic modulus

Indexed keywords

ALPHA GALACTOSIDASE; DEOXYCHOLIC ACID; DODECYL SULFATE SODIUM; EDETIC ACID; EPITOPE; GLUTARALDEHYDE; TRYPSIN;

ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BOVINE PERICARDIUM; CONTROLLED STUDY; COW; DECELLULARIZATION; DNA CONTENT; EXTRACELLULAR MATRIX; HEART VALVE BIOPROSTHESIS; IMMUNOBLOTTING; IMMUNOGENICITY; INTERMETHOD COMPARISON; NONHUMAN; PERICARDIUM; PRIORITY JOURNAL; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE FIXATION; TISSUE PREPARATION; WESTERN BLOTTING; YOUNG MODULUS;

ANIMALS; BIOCOMPATIBLE MATERIALS; BIOMECHANICS; BIOPROSTHESIS; CATTLE; CELL SEPARATION; CROSS-LINKING REAGENTS; DNA; ELASTIC MODULUS; GLUTARAL; HUMANS; MATERIALS TESTING; PERICARDIUM; TISSUE FIXATION; TRANSPLANTATION, HETEROLOGOUS; TRISACCHARIDES;

EID: 84866499244     PISSN: 0908665X     EISSN: 13993089     Source Type: Journal    
DOI: 10.1111/j.1399-3089.2012.00719.x     Document Type: Article

References (34)

1. Naso F, Gandaglia A, Iop L, Spina M, Gerosa G,. First quantitative assay of alpha-Gal in soft tissues: presence and distribution of the epitope before and after cell removal from xenogeneic heart valves. Acta Biomater 2011; 7: 1728-1734.
2. Griffiths LG, Choe LH, Reardon KF, Dow SW, Christopher Orton E,. Immunoproteomic identification of bovine pericardium xenoantigens. Biomaterials 2008; 29: 3514-3520.
3. Kasimir M, Rieder E, Seebacher G, et al., Presence and elimination of the xenoantigen gal (alpha1, 3) gal in tissue-engineered heart valves. Tissue Eng 2006; 11: 1274-1280.
4. Aupart MR, Mirza A, Meurisse YA, et al., Perimount pericardial bioprosthesis for aortic calcified stenosis: 18-year experience with 1133 patients. J Heart Valve Dis 2006; 15: 768-775; discussion 775-6.
5. Cebotari S, Tudorache I, Ciubotaru A, et al., Use of fresh decellularized allografts for pulmonary valve replacement may reduce the reoperation rate in children and young adults: early report. Circulation 2011; 124: S115-S123.
6. Da Costa FDA, Costa ACBA, Prestes R, et al., The early and midterm function of decellularized aortic valve allografts. Ann Thorac Surg 2010; 90: 1854-1860.
7. Fung YC,. Elasticity of soft tissues in simple elongation. Am J Physiol 1967; 213: 1532-1544.
8. Li K, Sun W,. Simulated thin pericardial bioprosthetic valve leaflet deformation under static pressure-only loading conditions: implications for percutaneous valves. Ann Biomed Eng 2010; 38: 2690-2701.
9. Páez JMG, Jorge-Herrero E,. Assessment of pericardium in cardiac bioprotheses: a review. J Biomater Appl 1999; 13: 351-388.
10. Sacks MS, Chuong CJ,. Orthotropic mechanical properties of chemically treated bovine pericardium. Ann Biomed Eng 1998; 26: 892-902.
11. Mendoza-Novelo B, Avila EE, Cauich-Rodríguez JV, et al., Decellularization of pericardial tissue and its impact on tensile viscoelasticity and glycosaminoglycan content. Acta Biomater 2010; 7: 1241-1248.
12. Oswal D, Korossis S, Mirsadraee S, et al., Biomechanical characterization of decellularized and cross-linked bovine pericardium. J Heart Valve Dis 2007; 16: 165-174.
13. Yang M, Chen C, Wang X, Zhu Y, Gu YJ,. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. J Biomed Mater Res B Appl Biomater 2009; 91: 354-361.
14. Mendelson K, Schoen FJ,. Heart valve tissue engineering: concepts, approaches, progress, and challenges. Ann Biomed Eng 2006; 34: 1799-1819.
15. Zioupos P, Barbenel JC, Fisher J,. Mechanical and optical anisotropy of bovine pericardium. Med Biol Eng Comput 1992; 30: 76-82.
16. Baraki H, Tudorache I, Braun M, et al., Orthotopic replacement of the aortic valve with decellularized allograft in a sheep model. Biomaterials 2009; 30: 6240-6246.
17. Laemmli UK,. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-685.
18. Penrose R,. A generalized inverse for matrices. Proc Camb Philol Soc 1955; 51: 406-413.
19. Akhyari P, Aubin H, Gwanmesia P, et al., The quest for an optimized protocol for whole heart decellularization: a comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities. Tissue Eng Part C Methods 2011; 17: 915-926.
20. Liao J, Yang L, Grashow J, Sacks MS,. The relation between collagen fibril kinematics and mechanical properties in the mitral valve anterior leaflet. J Biomech Eng 2007; 129: 78-87.
21. Vesely I, Lozon A,. Natural preload of aortic valve leaflet components during glutaraldehyde fixation: effects on tissue mechanics. J Biomech 1993; 26: 121-131.
22. Langdon SE, Chernecky R, Pereira CA, Abdulla D, Lee JM,. Biaxial mechanical/structural effects of equibiaxial strain during crosslinking of bovine pericardial xenograft materials. Biomaterials 1999; 20: 137-153.
23. Gilbert TW, Sellaro TL, Badylak SF,. Decellularization of tissues and organs. Biomaterials 2006; 27: 3675-3683.
24. Böer U, Lohrenz A, Klingenberg M, et al., The effect of detergent-based decellularization procedures on cellular proteins and immunogenicity in equine carotid artery grafts. Biomaterials 2011; 32: 9730-9737.
25. Badylak SF, Taylor D, Uygun K,. Whole-organ tissue engineering: decellularization and recellularization of three-dimensional matrix scaffolds. Annu Rev Biomed Eng 2011; 13: 27-53.
26. Rieder E, Kasimir M, Silberhumer G, et al., Decellularization protocols of porcine heart valves differ importantly in efficiency of cell removal and susceptibility of the matrix to recellularization with human vascular cells. J Thorac Cardiovasc Surg 2004; 127: 399-405.
27. Simon P, Kasimir MT, Seebacher G, et al., Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg 2003; 23: 1002-1006; discussion 1006.
28. Kalejs M, Stradins P, Lacis R, et al., St Jude Epic heart valve bioprostheses versus native human and porcine aortic valves-comparison of mechanical properties. Interact Cardiovasc Thorac Surg 2009; 8: 553-556.
29. Rousseau EP, Sauren AA, Van Hout MC, Van Steenhoven AA,. Elastic and viscoelastic material behaviour of fresh and glutaraldehyde-treated porcine aortic valve tissue. J Biomech 1983; 16: 339-348.
30. Stephens EH, Chu C, Grande-Allen KJ,. Valve proteoglycan content and glycosaminoglycan fine structure are unique to microstructure, mechanical load and age: relevance to an age-specific tissue-engineered heart valve. Acta Biomater 2008; 4: 1148-1160.
31. Cigliano A, Gandaglia A, Lepedda AJ, et al., Fine structure of glycosaminoglycans from fresh and decellularized porcine cardiac valves and pericardium. Biochem Res Int 2012; 2012: 979351.
32. Smuts AN, Blaine DC, Scheffer C, et al., Application of finite element analysis to the design of tissue leaflets for a percutaneous aortic valve. J Mech Behav Biomed Mater 2011; 4: 85-98.
33. Kortsmit J, Rutten MCM, Wijlaars MW, Baaijens FPT,. Deformation- controlled load application in heart valve tissue engineering. Tissue Eng Part C Methods 2009; 15: 707-716.
34. Mcgregor CGA, Carpentier A, Lila N, Logan JS, Byrne GW,. Cardiac xenotransplantation technology provides materials for improved bioprosthetic heart valves. J Thorac Cardiovasc Surg 2011; 141: 269-275.